Guangdong Hybribio Biotech Co Ltd (300639) — Cash Flow-to-Debt Ratio
Guangdong Hybribio Biotech Co Ltd (300639) has a Cash Flow-to-Debt Ratio of 0.12x as of September 2025, meaning its operating cash flow of CN¥66.39 Million could theoretically repay 0% of its total liabilities (CN¥553.76 Million) in one year. Check total reinvestment intensity of Guangdong Hybribio Biotech Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Guangdong Hybribio Biotech Co Ltd Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Guangdong Hybribio Biotech Co Ltd across 14 annual periods. Also explore 300639 total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Guangdong Hybribio Biotech Co Ltd (2012–2025)
Year-by-year debt coverage analysis for Guangdong Hybribio Biotech Co Ltd. For market capitalisation and broader financial context, see 300639 market cap.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.70x | CN¥341.61 Million | CN¥485.86 Million | ▲ +414.5% |
| 2024 | 0.14x | CN¥78.78 Million | CN¥576.44 Million | ▼ -73.2% |
| 2023 | 0.51x | CN¥319.60 Million | CN¥627.05 Million | ▼ -41.4% |
| 2022 | 0.87x | CN¥1.31 Billion | CN¥1.50 Billion | ▲ +4.3% |
| 2021 | 0.83x | CN¥631.34 Million | CN¥756.37 Million | ▼ -13.5% |
| 2020 | 0.96x | CN¥311.30 Million | CN¥322.69 Million | ▼ -4.0% |
| 2019 | 1.00x | CN¥112.83 Million | CN¥112.33 Million | ▲ +35.2% |
| 2018 | 0.74x | CN¥80.39 Million | CN¥108.17 Million | ▼ -7.3% |
| 2017 | 0.80x | CN¥79.17 Million | CN¥98.74 Million | ▼ -2.4% |
| 2016 | 0.82x | CN¥63.63 Million | CN¥77.49 Million | ▲ +35.7% |
| 2015 | 0.60x | CN¥48.47 Million | CN¥80.11 Million | ▼ -28.3% |
| 2014 | 0.84x | CN¥34.65 Million | CN¥41.06 Million | ▲ +193.6% |
| 2013 | 0.29x | CN¥22.89 Million | CN¥79.64 Million | ▼ -30.4% |
| 2012 | 0.41x | CN¥16.08 Million | CN¥38.96 Million | — |